Abstract.In this study, we investigated the value of thyroxine administration to prevent recurrence after bilateral subtotal thyroidectomy for multinodular goiter. Patients that had benign multinodular goiter were operated on with the same surgical principles: ligation of both superior and inferior thyroid arteries on both sides, bilateral subtotal resection of thyroid gland including all visible nodules. On the 3rd postoperative day, the patients were divided into two groups: with 100 microgram 1-thyroxine daily (Thyroxine group) or no therapy (Control group). No recurrences were encountered among 40 patients followed up for 6 months and 20 patients for at least one year. One patient in the control group developed manifest hypothyroidism (5.3%). The mean TSH level of the control group was significantly higher than that of thyroxine group at 1st, 2nd, 3rd, 4th, 5th, 6th, and 12th months. At the end of the first year, the mean TSH level of the control group was four times that of the normal.On the other hand, the mean TSH level of the thyroxine group was within normal limits but not suppressed.In conclusion, we found that the pituitary-thyroid axis did not become normal spontaneously one year after thyroidectomy. Therefore, postoperative thyroxine administration seems to be of value, especially in endemic regions like Turkey. RECURRENCE of the goiter after surgical treatment in euthyroid patients is still a common problem. Different series revealed high recurrence rates of up to half of the patients in long-term follow-up. Today second surgery accounts for approximately 15% of all thyroidectomies [1]. The complication rate of surgery for recurrence is higher than that of primary operation [21.Turkey is an endemic goiter country with severe iodine deficiency (total goiter rate > 30%) [3] . The recurrence rates of the Turkish series have been quite high. Ibis and coworkers reported a 67.5% overall recurrence rate in a nuclear medicine based study [4].In a surgical prospective series, Calik and colleagues found a 17% recurrence rate [5]. Both authors recommended postoperative thyroxine prophylaxis after thyroidectomy for nodular goiter. However, the number of prospective studies that investigate the efficacy of thyroxine administration in our country is very limited. In this paper, we presented the shortterm results of a prospective, randomized, nonplacebo controlled study on thyroxine prophylaxis after bilateral subtotal thyroidectomy for multinodular euthyroid goiter.
Patientsand Methods